A detailed history of Citigroup Inc transactions in Prokidney Corp Ord Shs Cl A(Cy stock. As of the latest transaction made, Citigroup Inc holds 75,150 shares of PROK stock, worth $135,270. This represents 0.0% of its overall portfolio holdings.

Number of Shares
75,150
Previous 73,149 2.74%
Holding current value
$135,270
Previous $179,000 19.55%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1.8 - $2.5 $3,601 - $5,002
2,001 Added 2.74%
75,150 $144,000
Q2 2024

Aug 12, 2024

BUY
$1.44 - $4.2 $92,878 - $270,895
64,499 Added 745.65%
73,149 $179,000
Q1 2024

May 10, 2024

BUY
$1.2 - $1.76 $2,541 - $3,727
2,118 Added 32.42%
8,650 $14,000
Q4 2023

Feb 09, 2024

BUY
$1.21 - $4.76 $7,800 - $30,687
6,447 Added 7584.71%
6,532 $11,000
Q3 2023

Nov 09, 2023

SELL
$4.32 - $13.08 $82,352 - $249,344
-19,063 Reduced 99.56%
85 $0
Q2 2023

Aug 10, 2023

BUY
$9.0 - $13.0 $165,375 - $238,875
18,375 Added 2377.1%
19,148 $214,000
Q1 2023

May 11, 2023

BUY
$6.1 - $13.78 $36 - $82
6 Added 0.78%
773 $8,000
Q4 2022

Feb 09, 2023

BUY
$5.47 - $11.38 $4,195 - $8,728
767 New
767 $5,000

Others Institutions Holding PROK

About PROKIDNEY CORP ORD SHS CL A(CY


  • Ticker PROK
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,540,200
  • Market Cap $111M
More about PROK
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.